Skip to main content
Log in

Cost effectiveness of PrEP greater in high-risk PWID

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Fu R, et al. Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs. AIDS : 13 Jan 2018. Available from: URL: http://doi.org/10.1097/QAD.0000000000001747

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cost effectiveness of PrEP greater in high-risk PWID. PharmacoEcon Outcomes News 795, 8 (2018). https://doi.org/10.1007/s40274-018-4646-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4646-3

Navigation